POLY MEDICURE
Back to Cashflow Statement
|
POLY MEDICURE Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹240 Cr | ₹266 Cr | ₹191 Cr | ₹123 Cr | ₹119 Cr |
What is the latest Cash Flow from Operating Activities ratio of POLY MEDICURE ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹240 Cr |
| Mar2024 | ₹266 Cr |
| Mar2023 | ₹191 Cr |
| Mar2022 | ₹123 Cr |
| Mar2021 | ₹119 Cr |
How is Cash Flow from Operating Activities of POLY MEDICURE Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹240 Cr | -9.64 | |
| Mar2024 | ₹266 Cr | 39.27 | |
| Mar2023 | ₹191 Cr | 54.73 | |
| Mar2022 | ₹123 Cr | 3.99 | |
| Mar2021 | ₹119 Cr | - | |
Compare Cash Flow from Operating Activities of peers of POLY MEDICURE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| POLY MEDICURE | ₹16,935.8 Cr | -2.7% | -0.2% | -22.1% | Stock Analytics | |
| LENSKART SOLUTIONS | ₹97,203.2 Cr | 4.6% | 8.2% | NA | Stock Analytics | |
| LAXMI DENTAL | ₹1,199.6 Cr | -2.5% | -3.2% | -51.8% | Stock Analytics | |
| 3B BLACKBIO DX | ₹1,105.1 Cr | 2.5% | 7.2% | -20.6% | Stock Analytics | |
| PREVEST DENPRO | ₹468.1 Cr | 2.4% | 0.1% | -28.8% | Stock Analytics | |
| NURECA | ₹297.8 Cr | 14.6% | 30.5% | 2.9% | Stock Analytics | |
POLY MEDICURE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| POLY MEDICURE | -2.7% |
-0.2% |
-22.1% |
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses